Viewing StudyNCT00232050



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00232050
Status: COMPLETED
Last Update Posted: 2011-10-25
First Post: 2005-10-03

Brief Title: Study of Omalizumab in Moderate to Severe Bronchial Asthma
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Asthma
Keywords:
Name View
Asthma IgE Omalizumab View